相关实验视频
Updated: Jul 23, 2025
07:56
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
Published on: July 22, 2019
11.3K
工程纳米材料来增强CRISPR/Cas9基因编辑用于癌症治疗
Ke Yi1, Huimin Kong1, Yeh-Hsing Lao2
1Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, P. R. China.
Advanced materials (Deerfield Beach, Fla.)
|July 12, 2023
概括
非病毒CRISPR/Cas9纳米配方为癌症基因编辑提供了更安全,更有效的方法. 这些先进的系统克服了病毒传递的局限性,为新的癌症纳米医学疗法铺平了道路.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 癌症治疗 癌症治疗
背景情况:
- 通过修改瘤基因和免疫细胞,CRISPR/Cas9基因编辑显示出癌症治疗的潜力.
- 目前的CRISPR/Cas9病毒传递方法在癌症治疗中面临安全性和包装限制.
- 非病毒纳米配方代表了瘤学中CRISPR/Cas9输送的新兴替代品.
研究的目的:
- 审查用于癌症治疗的非病毒CRISPR/Cas9传递系统的进展.
- 讨论这些纳米配方在克服当前治疗局限性的潜力.
- 为设计有效的基于CRISPR/Cas9的癌症纳米医学提供视角.
主要方法:
- 对非病毒CRISPR/Cas9传递策略的当前文献的综述.
- 对纳米配方工程进行分析,以提高安全性,效率和准.
- 对癌症纳米医学的翻译潜力的讨论.
主要成果:
- 与病毒载体相比,非病毒纳米配方提供了更高的安全性和包装能力.
- 优化的纳米配方可以改善癌症基因编辑的药理动力学和向性.
- 这些进展解决了阻碍CRISPR/Cas9癌症治疗的关键局限性.
结论:
- 非病毒CRISPR/Cas9纳米配方在推进癌症基因编辑方面具有显著的前景.
- 纳米医药设计的进一步发展对于将这些技术转化为临床应用至关重要.
- 基于CRISPR/Cas9的癌症纳米医学为有效的癌症治疗提供了潜在的新途径.
相关概念视频
01:28CRISPR/Cas9 Genome Editing
72
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
72
01:59CRISPR
52.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.4K
02:53CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
02:31Homologous Recombination
50.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.7K
00:49What is Genetic Engineering?
74.4K
Overview
74.4K